Genelux Corporation (GNLX)
(Real Time Quote from BATS)
$3.56 USD
-0.27 (-7.05%)
Updated May 13, 2024 03:41 PM ET
2-Buy of 5 2
F Value D Growth F Momentum F VGM
Income Statements
Fiscal Year end for Genelux Corporation falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 0 | 11 | 0 | NA | NA |
Cost Of Goods | 0 | 0 | 0 | NA | NA |
Gross Profit | 0 | 11 | 0 | NA | NA |
Selling & Adminstrative & Depr. & Amort Expenses | 24 | 14 | 15 | 0 | 0 |
Income After Depreciation & Amortization | -24 | -3 | -15 | 0 | 0 |
Non-Operating Income | -4 | 0 | -1 | NA | NA |
Interest Expense | 0 | 1 | 1 | NA | NA |
Pretax Income | -28 | -4 | -16 | NA | NA |
Income Taxes | 0 | 1 | 0 | NA | NA |
Minority Interest | 0 | 0 | 0 | NA | NA |
Investment Gains/Losses | 0 | 0 | 0 | NA | NA |
Other Income/Charges | 0 | 0 | 0 | NA | NA |
Income From Cont. Operations | -28 | -5 | -16 | NA | NA |
Extras & Discontinued Operations | 0 | 0 | 0 | NA | NA |
Net Income (GAAP) | -28 | -5 | -16 | NA | NA |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -23 | -2 | -14 | 0 | 0 |
Depreciation & Amortization (Cash Flow) | 1 | 1 | 1 | NA | NA |
Income After Depreciation & Amortization | -24 | -3 | -15 | 0 | 0 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 24.43 | NA | NA | NA | NA |
Diluted EPS Before Non-Recurring Items | -1.14 | NA | NA | NA | NA |
Diluted Net EPS (GAAP) | -1.16 | -0.57 | NA | NA | NA |
Fiscal Year end for Genelux Corporation falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | 0.01 | 0.00 | 0.00 | 0.00 | 0.17 |
Cost Of Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | 0.01 | 0.00 | 0.00 | 0.00 | 0.17 |
SG&A, R&D, and Dept/Amort Expenses | 8.12 | 7.00 | 5.31 | 5.39 | 6.64 |
Income After SG&A, R&D, and Dept/Amort Expenses | -8.11 | -7.00 | -5.31 | -5.39 | -6.47 |
Non-Operating Income | 0.27 | 0.24 | -0.04 | -0.40 | -3.76 |
Interest Expense | 0.00 | 0.01 | 0.00 | 0.02 | 0.14 |
Pretax Income | -7.85 | -6.77 | -5.35 | -5.82 | -10.36 |
Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | -7.85 | -6.77 | -5.35 | -5.82 | -10.36 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | -7.85 | -6.77 | -5.35 | -5.82 | -10.36 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | 26.85 | 27.33 | 26.21 | 25.07 | NA |
Diluted EPS Before Non-Recurring Items | -0.29 | -0.25 | -0.20 | -0.21 | NA |
Diluted Net EPS (GAAP) | -0.29 | -0.20 | -0.20 | -0.23 | -0.53 |